Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ole Kirk

Showing results (91-100 of 171) with videos related to

Pageof 18
Sort By:
Ugeskrift for Laeger|March 18, 2021
[Clinical management of hospitalised patients with COVID-19]Klaus Nielsen Jeschke, Nanna Reiter, Anne-Mette Hvas, et al.
Plos Medicine|April 1, 2015
Development and validation of a risk score for chronic kidney disease in HIV infection using prospective cohort data from the D:A:D studyAmanda Mocroft, Jens D Lundgren, Michael Ross, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|September 3, 2010
Dialysis and renal transplantation in HIV-infected patients: a European surveyJoan Carles Trullas, Amanda Mocroft, Federico Cofan, et al.
The Journal of Infectious Diseases|August 4, 2016
Renal Impairment and Cardiovascular Disease in HIV-Positive Individuals: The D:A:D StudyLene Ryom, Jens D Lundgren, Mike Ross, et al.
European Journal of Preventive Cardiology|April 18, 2015
An updated prediction model of the global risk of cardiovascular disease in HIV-positive persons: The Data-collection on Adverse Effects of Anti-HIV Drugs (D:A:D) studyNina Friis-Møller, Lene Ryom, Colette Smith, et al.
The Journal of Infectious Diseases|February 5, 2014
Prognostic value of vitamin D level for all-cause mortality, and association with inflammatory markers, in HIV-infected personsLeah Shepherd, Jean-Claude Souberbielle, Jean-Philippe Bastard, et al.
AIDS (London, England)|October 4, 2008
HIV-induced immunodeficiency and mortality from AIDS-defining and non-AIDS-defining malignanciesAntonella d'Arminio Monforte, Donald Abrams, Christian Pradier, et al.
Open Forum Infectious Diseases|March 1, 2016
Antiretroviral Drugs and Risk of Chronic Alanine Aminotransferase Elevation in Human Immunodeficiency Virus (HIV)-Monoinfected Persons: The Data Collection on Adverse Events of Anti-HIV Drugs StudyHelen Kovari, Caroline A Sabin, Bruno Ledergerber, et al.
AIDS (London, England)|July 28, 2023
Long-term outcomes after tuberculosis for people with HIV in eastern EuropeChristian Kraef, Adrian Bentzon, Ashley Roen, et al.
The New England Journal of Medicine|April 27, 2007
Class of antiretroviral drugs and the risk of myocardial infarction, Nina Friis-Møller, Peter Reiss, et al.
Pageof 18

Showing results (91-100 of 171) with videos related to

Sort By:
Pageof 18
Ugeskrift for Laeger|March 18, 2021
[Clinical management of hospitalised patients with COVID-19]Klaus Nielsen Jeschke, Nanna Reiter, Anne-Mette Hvas, et al.
Plos Medicine|April 1, 2015
Development and validation of a risk score for chronic kidney disease in HIV infection using prospective cohort data from the D:A:D studyAmanda Mocroft, Jens D Lundgren, Michael Ross, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|September 3, 2010
Dialysis and renal transplantation in HIV-infected patients: a European surveyJoan Carles Trullas, Amanda Mocroft, Federico Cofan, et al.
The Journal of Infectious Diseases|August 4, 2016
Renal Impairment and Cardiovascular Disease in HIV-Positive Individuals: The D:A:D StudyLene Ryom, Jens D Lundgren, Mike Ross, et al.
European Journal of Preventive Cardiology|April 18, 2015
An updated prediction model of the global risk of cardiovascular disease in HIV-positive persons: The Data-collection on Adverse Effects of Anti-HIV Drugs (D:A:D) studyNina Friis-Møller, Lene Ryom, Colette Smith, et al.
The Journal of Infectious Diseases|February 5, 2014
Prognostic value of vitamin D level for all-cause mortality, and association with inflammatory markers, in HIV-infected personsLeah Shepherd, Jean-Claude Souberbielle, Jean-Philippe Bastard, et al.
AIDS (London, England)|October 4, 2008
HIV-induced immunodeficiency and mortality from AIDS-defining and non-AIDS-defining malignanciesAntonella d'Arminio Monforte, Donald Abrams, Christian Pradier, et al.
Open Forum Infectious Diseases|March 1, 2016
Antiretroviral Drugs and Risk of Chronic Alanine Aminotransferase Elevation in Human Immunodeficiency Virus (HIV)-Monoinfected Persons: The Data Collection on Adverse Events of Anti-HIV Drugs StudyHelen Kovari, Caroline A Sabin, Bruno Ledergerber, et al.
AIDS (London, England)|July 28, 2023
Long-term outcomes after tuberculosis for people with HIV in eastern EuropeChristian Kraef, Adrian Bentzon, Ashley Roen, et al.
The New England Journal of Medicine|April 27, 2007
Class of antiretroviral drugs and the risk of myocardial infarction, Nina Friis-Møller, Peter Reiss, et al.
Pageof 18